What is the maximum recommended daily dose of fexofenadine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Daily Dose of Fexofenadine

The maximum recommended daily dose of fexofenadine is 180 mg once daily for adults and children ≥12 years, or 60 mg twice daily (total 120 mg/day) for the same age group. 1

Standard FDA-Approved Dosing

According to the FDA drug label, the approved dosing regimens are 1:

For adults and children ≥12 years:

  • Seasonal allergic rhinitis: 60 mg twice daily OR 180 mg once daily
  • Chronic idiopathic urticaria: 60 mg twice daily OR 180 mg once daily

For children 6-11 years:

  • 30 mg twice daily (total 60 mg/day maximum)

Renal impairment adjustments:

  • Adults/children ≥12 years: Start with 60 mg once daily
  • Children 6-11 years: Start with 30 mg once daily

Higher Doses in Clinical Practice

While the FDA-approved maximum is 180 mg daily, second-generation antihistamines like fexofenadine are often used at 2-4 times FDA-approved doses in mast cell activation disorders 2. This practice is supported by expert opinion for conditions like mast cell activation syndrome (MCAS), where fexofenadine and cetirizine may be dosed at higher levels to control symptoms.

Safety at Suprapharmacologic Doses

The evidence strongly supports fexofenadine's safety profile even at doses exceeding standard recommendations:

  • Fexofenadine has no sedative properties even at higher than FDA-approved doses when treating allergic rhinitis 3
  • Studies in healthy volunteers demonstrated no QTc prolongation or cardiovascular effects at single doses up to 800 mg once daily and multiple doses up to 690 mg twice daily for 28 days 4
  • No brain H1-receptor occupancy occurs with fexofenadine, confirming its non-sedating profile regardless of dose 5

Key Clinical Distinctions

Fexofenadine stands apart from other second-generation antihistamines:

  • Unlike loratadine and desloratadine, which develop sedative properties at higher-than-recommended doses, fexofenadine maintains its non-sedating profile 3
  • Unlike cetirizine (which causes sedation in 13.7% at standard 10 mg doses), fexofenadine causes no performance impairment even at elevated doses 3, 6

Practical Dosing Algorithm

For standard allergic conditions (rhinitis, urticaria):

  • Start with 180 mg once daily or 60 mg twice daily
  • Maximum: 180 mg/day per FDA labeling

For refractory symptoms or mast cell disorders:

  • May increase to 2-4 times standard dosing (360-720 mg/day) under specialist guidance
  • This is off-label but supported by safety data and expert consensus 2

Important caveat: While fexofenadine has an exceptional safety profile at high doses, the standard FDA-approved maximum of 180 mg daily should be the starting point for routine clinical practice, with dose escalation reserved for specialist management of refractory conditions.

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

Cardiovascular safety of fexofenadine HCl.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Research

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.